Notably, compared to the C57BL/6 mice group, there was a significant increase in tumor volumes and weights in the PRMT5 knockdown groups with CD8 deficiency, which corresponded to lower survival rates than those observed in the control group (Figure 3A–D). The gene discussed is CD8A; the disease is neoplasm.